HOME >> BIOLOGY >> NEWS
Liver signal critical for insulin's brain action

New research in the April 5, 2006 Cell Metabolism identifies a key player in the body's ability to respond to insulin action in the brain by ratcheting down the export of blood sugar from the liver. The findings point to a potential new drug target for the treatment of type 2 diabetes, according to the researchers.

The group found evidence in mice that the gene STAT3 in liver mediates the effects of brain insulin. The STAT3 response depends upon interleukin-6, a chemical involved in the body's reaction to stresses, they reported.

Earlier evidence by the researchers showed that the gene STAT3 controls glucose balance by limiting the activity of genes that manufacture glucose in the liver. However, the mechanism by which nutritional and hormonal status controls hepatic STAT3 had remained unknown, said study author Masato Kasuga of Kobe University Graduate School of Medicine in Japan.

Insulin secreted by the pancreas after a meal normally allows body tissues, such as muscle and fat, to take up the blood sugar glucose. "In liver, which is responsible for minute-by-minute regulation of blood glucose levels and can export glucose as well as store it, insulin not only promotes the storage of glucose but also inhibits the production of sugar for export," explained Martin Myers, Jr., in a preview. The brain participates in the regulation of glucose production and insulin response by sensing and responding to nutrient levels and hormonal signals of energy intake and storage.

In those with diabetes due to a lack of normal insulin or insulin resistance, blood sugar rises, a condition that can lead to tissue damage. An increase in glucose issued from the liver is largely responsible, Kasuga said.

Now, the researchers have found in mice that an increase in blood insulin levels, achieved by administering glucose or insulin, leads to the activation of STAT3 in liver. The response depends upon the hormone's effects in the brain and an increas
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
4-Apr-2006


Page: 1 2

Related biology news :

1. Liverpool amongst first in UK to install unique DNA sequencing technology
2. University of Liverpool launches 10 million small animal teaching hospital
3. Liverpool scientists work to improve water quality in Ghana
4. Liver regeneration may be simpler than previously thought
5. 2.5M boost for marine biology in Liverpool
6. International scientists to present MRSA research in Liverpool
7. UC Davis, Lawrence Livermore researchers
8. Liver cancer linked to cellular repair pathway
9. Liver transplant patients gain same benefits from CellCept as kidney transplant patients
10. Liver metabolism goes to pot
11. Liverpool vet creates pain relief diet for arthritic dogs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... ... September 30, 2019 , ... As human induced pluripotent stem cells (hiPSCs) move ... development and diseases of the human heart, there is an increasing need for stable ... cells to be clearly and easily recorded. A study released today in STEM CELLS ...
(Date:9/25/2019)... , ... September 25, 2019 , ... ... Austin, TX, have placed over 20,000 dental implants for a variety of procedures, ... technical zygomatic and pterygoid dental implants. Dental implants offer patients permanent ...
(Date:9/25/2019)... , ... September 25, 2019 , ... Deep Science ... Cancer Research UK, the world’s largest independent funder of cancer research. , Deep Science ... that takes a systems-level view of the opportunity from the start, both at the ...
Breaking Biology News(10 mins):
(Date:9/24/2019)... Kong (PRWEB) , ... September 24, 2019 , ... Drug ... 2019 by the World Health Organization, with MRSA becoming one of the most serious ... there were 1,218 reported cases of community-associated MRSA (CA-MRSA), or a seven-fold of the ...
(Date:9/24/2019)... ... September 24, 2019 , ... In the past three years, the ... faculty at South Dakota School of Mines & Technology that expands human ... to surfaces to form a slimy and yet strong layer which is commonly known ...
(Date:9/17/2019)... ... September 17, 2019 , ... Geneticure, Inc., a Rochester ... today that the U.S. Patent and Trademark Office (USPTO) and European Patent Office ... class recommendations for hypertension treatment. , The patent applies to Geneticure’s first ...
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate ... China Focus @ Biotech Week Boston, a forum organized by MyBioGate, Inc. and ... innovation. , After a careful process of evaluation, twelve companies out of over ...
Breaking Biology Technology:
Cached News: